- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:32 | Psychedelika-Sektor vor Neubewertung: Warum der Eli-Lilly-Milliardendeal die Spielregeln für die gesamte Branche verändert | Small- & Micro Cap Investment | |||
| Do | EMYRIA LIMITED: Emyria to Present at Upcoming Investor and Industry Events | 8 | ASX | ||
| EMYRIA Aktie jetzt für 0€ handeln | |||||
| 24.06. | EMYRIA LIMITED: Emyria Depression Program Shows Positive Results | 4 | ASX | ||
| 22.06. | Daily Special: Etherstack, Acusensus, Emyria, Fenix Resources | 2 | Finance News Network | ||
| 22.06. | EMYRIA LIMITED: Emyria Confirms NSW Workforce Ahead of Clinic Opening | 3 | ASX | ||
| 16.06. | EMYRIA LIMITED: Emyria Company Update - Video Presentation | 2 | ASX | ||
| 11.06. | EMYRIA LIMITED: Emyria Company Update Presentation | 4 | ASX | ||
| 08.06. | EMYRIA LIMITED: Notification of cessation of securities - EMD | - | ASX | ||
| 29.05. | EMYRIA LIMITED: Change of Director's Interest Notice x 2 | 3 | ASX | ||
| 29.05. | EMYRIA LIMITED: Notification regarding unquoted securities - EMD | - | ASX | ||
| 29.05. | EMYRIA LIMITED: Application for quotation of securities - EMD | - | ASX | ||
| 28.05. | Emyria Poised for Operational Boost as TGA Broadens Psych-Therapy Prescriber Access | 1 | smallcaps.com.au | ||
| 28.05. | EMYRIA LIMITED: TGA Update to Accelerate Empax Therapist Recruitment | 1 | ASX | ||
| 20.05. | Emyria opens first Victoria Empax clinic | 3 | Stockhead | ||
| 18.05. | Daily Special: Emyria, Prairie Lithium, Challenger Gold | 5 | Finance News Network | ||
| 18.05. | EMYRIA LIMITED: Emyria Activates First Victorian Empax Clinic | 3 | ASX | ||
| 04.05. | EMYRIA LIMITED: March Quarter Investor Video Presentation | 8 | ASX | ||
| 01.05. | EMYRIA LIMITED: Results of General Meeting | - | ASX | ||
| 28.04. | EMYRIA LIMITED: Emyria Extends National Expansion into New South Wales | - | ASX | ||
| 28.04. | EMYRIA LIMITED: March 2026 Quarterly Activities Report and Appendix 4C | 2 | ASX |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,970 | +0,43 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| GERRESHEIMER | 27,600 | -3,09 % | Ihre wichtigsten Termine: Frische Q2-Zahlen von: BoA, Wells Fargo, Goldman Sachs, JPMorgan und Citigroup | © Foto: UnsplashGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 07:00 Uhr, Deutschland:... ► Artikel lesen | |
| OTTOBOCK | 57,00 | -1,55 % | DEUTSCHE BANK RESEARCH stuft Ottobock auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Ottobock mit einem Kursziel von 83 Euro auf "Buy" belassen. Analyst Falko Friedrichs rechnet mit starken Quartalsergebnissen... ► Artikel lesen | |
| TEMPRAMED TECHNOLOGIES | 0,301 | -3,53 % | TempraMed erweitert sein institutionelles Gesundheitsnetzwerk mit Meuhedet Health Services, einer führenden israelischen Gesundheitsorganisation mit mehr als einer Million Mitgliedern | Die Aufnahme der TempraMed-Produkte in das Programm von Meuhedet Health Services stärkt TempraMeds Strategie der
institutionellen B2B-Vermarktung im Zuge des Ausbaus von Erstattungsinitiativen... ► Artikel lesen | |
| GENEDX | 60,73 | +0,13 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| ADVANCED BIOMED | 9,000 | +1,12 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,54 | +0,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 26,260 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,340 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,090 | -0,05 % | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | ||
| BILLIONTOONE | 125,20 | +0,05 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,690 | 0,00 % | Aveanna Healthcare (AVAH): Best Future Stocks to Buy Under $10 | ||
| PROCEPT BIOROBOTICS | 19,220 | 0,00 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 31,750 | -0,06 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| HEARTFLOW | 24,540 | -0,08 % | Stifel reiterates HeartFlow stock rating after cardiology meeting |
EMYRIA LIMITED gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,026 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EMYRIA LIMITED finden Sie auf Wallstreet Online.